Scinovex
review Open AccessTop 1% cited

EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT)

Annals of the Rheumatic Diseases · 2006 · Vol. 65(10) · pp. 1312–1324
Weiya ZhangM DohertyT BardinE PascualV BarskovaP ConaghanJ GersterJ JacobsB LeebF LiotéG McCarthyP NetterG NukiF Perez-RuizA PignoneJ PimentãoL PunziE RoddyT UhligI Zimmermann-Gòrska
Gout, Hyperuricemia, Uric AcidUrticaria and Related ConditionsVenous Thromboembolism Diagnosis and ManagementMedicineGoutAllopurinolFebuxostatOdds ratioUricosuricBenzbromaronePhysical therapyInternal medicineIntensive care medicine

MeSH terms

Acute DiseaseDelphi TechniqueGoutGout SuppressantsHumansLife StyleRisk FactorsTreatment OutcomeEvidence-Based MedicineHyperuricemia

Funding

  • European League Against Rheumatism
Citations
1,414
FWCI
29.98
field-weighted impact
References
176
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.